Joshua Nathaniel Silverman, Director at Marker Therapeutics, holds 170.55K shares in Marker Therapeutics (Ticker: MRKR), holds 88.78K shares in TNF Pharmaceuticals (Ticker: TNFA). Most recently, Joshua Nathaniel Silverman ― shares of Marker Therapeutics on ― for an estimated value of ―.
What was Joshua Nathaniel Silverman’s latest transaction?
Joshua Nathaniel Silverman latest transaction was an Uninformative Buy of ―.
What was Joshua Nathaniel Silverman's most profitable transaction?
Joshua Nathaniel Silverman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Joshua Nathaniel Silverman's role in Marker Therapeutics?
Joshua Nathaniel Silverman's role in Marker Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.